Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies

Ann Rheum Dis. 2020 May;79(5):667-668. doi: 10.1136/annrheumdis-2020-217424. Epub 2020 Apr 2.

Authors

Sara Monti¹, Silvia Balduzzi², Paolo Delvino³, Elisa Bellis³, Verdiana Serena Quadrelli³, Carlomaurizio Montecucco³

Affiliations

¹ Rheumatology Department, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy sara.saramonti@gmail.com.
² Rheumatology Department, IRCCS Policlinico San Matteo, Pavia, Italy.
³ Rheumatology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

No abstract available

Keywords: antirheumatic agents; arthritis, rheumatoid; biological therapy; spondylitis, ankylosing.

Publication types

Letter

MeSH terms

Aged
Antirheumatic Agents / therapeutic use
Arthritis / complications*
Arthritis / drug therapy
Betacoronavirus*
COVID-19
Chronic Disease
Coronavirus Infections / complications*
Female
Humans
Immunosuppressive Agents / therapeutic use*
Male
Middle Aged
Pandemics
Pneumonia, Viral / complications*
SARS-CoV-2

Substances

Antirheumatic Agents
Immunosuppressive Agents